MCHIP is the USAID Bureau for Global Health’s flagship maternal, neonatal and child health (MNCH) program which focuses on reducing maternal, neonatal and child mortality and accelerating progress toward achieving Millennium Development Goals (MDGs) 4 and 5. Awarded to Jhpiego and partners in September 2008, MCHIP works with USAID missions, governments, nongovernmental organizations, local communities and partner agencies in developing countries to implement programs at scale for sustainable improvements in MNCH.
What we do
MCHIP and Newborn Health
By focusing on the three main causes of death and supporting the introduction and scale-up of evidence-based prevention and treatment interventions, MCHIP aims to contribute to the global reduction of neonatal mortality. In the process, the Program will be contributing to the reduction in Millennium Development Goal 4, as well as to USAID’s goal of reducing under-five mortality by 25% by 2013 in 30 priority countries, and to their newborn health pathway goals.
The MCHIP strategy for newborn health will:
- Follow the Paris Principles and work with partners including UNICEF, WHO and Saving Newborn Lives to provide catalytic inputs to support the introduction and expansion of evidence-based newborn care interventions;
- Scale up evidence-based approaches to improve newborn health by focusing on 30 priority MCH countries;
- Support integration of ENC packages into MCH systems;
- Assure that evidence-based ENC programs are documented and promoted at scale;
- Provide technical leadership in newborn health globally; and
- Strengthen and support strategic alliances that support implementation of newborn health programs at scale.
